Universe Pharmaceuticals INC (UPC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 12.29M |
| Enterprise value | -11.88M |
| Trailing P/E | 2.35 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.26 |
| Price/book (mrq) | 0.20 |
| Enterprise value/revenue | -0.25 |
| Enterprise value/EBITDA | -1.47 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -73.88% |
| S&P500 52-week change 3 | -14.73% |
| 52-week high 3 | 2.5000 |
| 52-week low 3 | 0.5000 |
| 50-day moving average 3 | 0.5971 |
| 200-day moving average 3 | 1.0362 |
Share statistics
| Avg vol (3-month) 3 | 36.36k |
| Avg vol (10-day) 3 | 19.91k |
| Shares outstanding 5 | 21.75M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 7.08M |
| % held by insiders 1 | 57.38% |
| % held by institutions 1 | 1.37% |
| Shares short (14 Sept 2022) 4 | 8.01k |
| Short ratio (14 Sept 2022) 4 | 0.16 |
| Short % of float (14 Sept 2022) 4 | 0.09% |
| Short % of shares outstanding (14 Sept 2022) 4 | 0.04% |
| Shares short (prior month 14 Aug 2022) 4 | 21.9k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 29 Sept 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 12.33% |
| Operating margin (ttm) | 14.01% |
Management effectiveness
| Return on assets (ttm) | 6.05% |
| Return on equity (ttm) | 10.56% |
Income statement
| Revenue (ttm) | 47.89M |
| Revenue per share (ttm) | 2.20 |
| Quarterly revenue growth (yoy) | -0.40% |
| Gross profit (ttm) | 25.33M |
| EBITDA | 7.2M |
| Net income avi to common (ttm) | 5.9M |
| Diluted EPS (ttm) | 0.2600 |
| Quarterly earnings growth (yoy) | -75.80% |
Balance sheet
| Total cash (mrq) | 28.58M |
| Total cash per share (mrq) | 1.31 |
| Total debt (mrq) | 4.41M |
| Total debt/equity (mrq) | 7.21 |
| Current ratio (mrq) | 5.06 |
| Book value per share (mrq) | 2.81 |
Cash flow statement
| Operating cash flow (ttm) | 3M |
| Levered free cash flow (ttm) | -14.28M |
© 2022 Yahoo. All rights reserved.
